Skip to content
Screener

Pre-Tax Income at other companies

CareDx logo
CareDxCDNA
$2.78M+127%
LivaNova logo
LivaNovaLIVN
$18.48M-44.5%
SRT
Strata Critical MedicalSRTA
$2.4M+249%
ICU Medical logo
ICU MedicalICUI
$23.14M-31.3%
Edwards Lifesciences logo
Edwards LifesciencesEW
$519.8M+29.9%
United Therapeutics logo
United TherapeuticsUTHR
$372.7M-8.7%

Other financials

Income statement

See full
Revenue$173.9M+21.2%
Gross profit$101.2M+14.7%
Operating income$13.3M-51.5%
Net income$7.3M-71.5%
EPS (diluted)$0.20-71.4%

Balance sheet

See full
Cash & equivalents$461.7M+48.9%
Total debt$409.9M+505%
Total equity$494.0M+85.5%
Total assets$1.4B+71.3%

Cash flow

See full
Operating cash flow$24.5M+959%
CapEx$36.7M+35.6%
Free cash flow-$12.1M+59.4%

Valuation

See full
Market cap$2.78B-31.3%
Enterprise value$2.73B-26.6%
P/E16.2×-40.3×
P/S4.4×-3.2×

Profitability

See full
Gross margin59.1%-0.4pp
Operating margin14.9%+4.1pp
Net margin27%+17.0pp
FCF margin23.8%

Returns & leverage

See full
Return on equity45.2%+22.2pp
Debt / equity0.8×+0.6×
Current ratio6.7×-2.4×

Where this comes from

Reported directly by TransMedics Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The source filing: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-206453
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Interest expense(7,170)(3,461)
Interest income and other income (expense), net2,3582,694
Total other expense, net(4,812)(767)
Income before income taxes8,48526,676
Provision for income taxes(1,170)(994)
Net income$7,315$25,682
Net income per share:
Basic$0.21$0.76

Item 1. Financial Statements (Unaudited)

FAQ

What is TransMedics Group, Inc.'s pre-tax income?
TransMedics Group, Inc. (TMDX) reported pre-tax income of $8.49M in Q1 2026.
How has TransMedics Group, Inc.'s pre-tax income changed year-over-year?
TransMedics Group, Inc.'s pre-tax income decreased by 68.2% year-over-year, from $26.68M to $8.49M.
What is the long-term trend for TransMedics Group, Inc.'s pre-tax income?
Over 3 years (2021 to 2025), TransMedics Group, Inc.'s pre-tax income has grown at a 34.5% compound annual growth rate (CAGR), from -$44.18M to $107.52M.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Ask your AI about TransMedics Group, Inc.'s pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude